A Randomized Open-Label Study of 3- Versus 5-Drug Combination Antiretroviral Therapy in Newly HIV-1–Infected Individuals

Markowitz, Martin; Evering, Teresa H.; Garmon, Donald; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 66(2):140-147, June 1, 2014.

Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults

Ruane, Peter J.; DeJesus, Edwin; Berger, Daniel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(4):449-455, August 1, 2013.

Transmitted Drug Resistance and Phylogenetic Relationships Among Acute and Early HIV-1–Infected Individuals in New York City

Castor, Delivette; Low, Andrea; Evering, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 61(1):1-8, September 1, 2012.

Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection: Final Results of a Randomized,...

Gotuzzo, Eduardo; Markowitz, Martin; Ratanasuwan, Winai; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 61(1):73-77, September 1, 2012.

Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection

Markowitz, Martin; Nguyen, Bach-Yen; Gotuzzo, Eduardo; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(3):350-356, November 2009.

Drug-Susceptible HIV-1 Infection Despite Intermittent Fixed-Dose Combination Tenofovir/Emtricitabine as Prophylaxis Is Associated With Low-Level Viremia, Delayed Seroconversion,...

Prada, Nicole; Davis, Brandi; Jean-Pierre, Patrick; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 49(2):117-122, October 2008.

Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection: Results of a...

Markowitz, Martin; Nguyen, Bach-Yen; Gotuzzo, Eduardo; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 46(2):125-133, October 1, 2007.

Long-Term Efficacy and Safety of Tipranavir Boosted With Ritonavir in HIV-1-Infected Patients Failing Multiple Protease Inhibitor Regimens: 80-Week Data From a Phase 2 Study

Markowitz, Martin; Slater, Leonard N; Schwartz, Robert; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 45(4):401-410, August 1, 2007.

Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected...

Markowitz, Martin; Morales-Ramirez, Javier O; Nguyen, Bach-Yen; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 43(5):509-515, December 15, 2006.

Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients

DeJesus, Edwin; Berger, Daniel; Markowitz, Martin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 43(1):1-5, September 2006.

Tracking the Prevalence of Transmitted Antiretroviral Drug-Resistant HIV-1: A Decade of Experience

Shet, Anita; Berry, Leslie; Mohri, Hiroshi; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 41(4):439-446, April 1, 2006.

Induction With Abacavir/Lamivudine/Zidovudine Plus Efavirenz for 48 Weeks Followed by 48-Week Maintenance With Abacavir/Lamivudine/Zidovudine Alone in Antiretroviral-Naive...

Markowitz, Martin; Hill-Zabala, Christina; Lang, Joseph; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 39(3):257-264, July 1, 2005.

Intensification of Antiretroviral Therapy Accelerates the Decay of the HIV-1 Latent Reservoir and Decreases, But Does Not Eliminate, Ongoing Virus Replication

Ramratnam, Bharat; Ribeiro, Ruy; He, Tian; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 35(1):33-37, January 1, 2004.

Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1-Infected Patients.

Kost, Rhonda G.; Hurley, Arlene; Zhang, Linqi; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 26(4):332-339, April 1, 2001.